☰ 🔍
🖊️Ask a Question
Electrical Engineering

Entacapone differs from tolcapone in the following respect/respects: A. It is shorter acting B. It acts only by inhibiting peripheral metabolism of levodopa C. It is not hepatotoxic D. All of the above are correct

by 0 views
Entacapone differs from tolcapone in the following
respect/respects:
A. It is shorter acting
B. It acts only by inhibiting peripheral
metabolism of levodopa
C. It is not hepatotoxic
D. All of the above are correct
0 like 0 dislike

1 Answer

by
D. All of the above are correct
0 like 0 dislike

Related questions

by trupti chikram asked Jul 23, 2021 0 views
The following is true about entacapone except: A. It acts by inhibiting degradation of dopamine in the brain B. If prolongs the therapeutic effect of levodopacarbidopa in parkinsonism C. It can accentuate levodopa induced dyskinesias D. It can cause diarrhoea as a side effec

The following is true about entacapone except: A. It acts by inhibiting degradation of dopamine in the brain B. If prolongs the therapeutic effect of levodopacarbidopa in parkinsonism C. It can accentuate levodopa induced dyskinesias D. It can cause diarrhoea as a side effec
Answer : A. It acts by inhibiting degradation of dopamine in the brain...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 24, 2021 0 views
Ranitidine differs from cimetidine in the following respect: A. It is less potent B. It is shorter acting C. It does not have antiandrogenic action D. It produces more CNS side effect

Ranitidine differs from cimetidine in the following respect: A. It is less potent B. It is shorter acting C. It does not have antiandrogenic action D. It produces more CNS side effect
Answer : C. It does not have antiandrogenic action...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 23, 2021 1 view
Ropinirole differs from bromocriptine in the following respect: A. It does not directly activate dopamine D2 receptors B. It produces milder gastrointestinal side effects C. In early cases of parkinsonism, it is less likely to need levodopa supplementation D. Both 'B' and 'C' are correct

Ropinirole differs from bromocriptine in the following respect: A. It does not directly activate dopamine D2 receptors B. It produces milder gastrointestinal side effects C. In early cases of parkinsonism, it is less likely to need levodopa supplementation D. Both 'B' and 'C' are correct
Answer : D. Both 'B' and 'C' are correct...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 23, 2021 0 views
In the treatment of parkinsonism, bromocriptine differs from levodopa in the following respects except: A. It does not need conversion to an active metabolite B. It has a longer duration of action C. It activates dopamine D2 receptors, with little/antagonistic action on D1 receptors D. It does not produce behavioral/psychiatric side effect

In the treatment of parkinsonism, bromocriptine differs from levodopa in the following respects except: A. It does not need conversion to an active metabolite B. It has a longer duration of ... with little/antagonistic action on D1 receptors D. It does not produce behavioral/psychiatric side effect
Answer : D. It does not produce behavioral/psychiatric side effects...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 23, 2021 0 views
The primary action by which entacapone and tolcapone enhance the therapeutic effect of levodopa-carbidopa in parkinsonism is: A. Inhibition of levodopa methylation in the liver B. Inhibition of dopamine methylation in the brain C. Inhibition of oxidative deamination of dopamine in the brain D. Facilitation of active transport of levodopa across brain capillaries

The primary action by which entacapone and tolcapone enhance the therapeutic effect of levodopa-carbidopa in parkinsonism is: A. Inhibition of levodopa methylation in the liver B. Inhibition of ... of dopamine in the brain D. Facilitation of active transport of levodopa across brain capillaries
Answer : A. Inhibition of levodopa methylation in the liver...

View solution
0 like 0 dislike
1 answer

50.5k questions

47.1k answers

240 comments

7.0k users

© 2025 Question Answer